Lipid Nanoparticles Lyophilization Methods and Compositions Patent

The European Patent Office has published patent application EP4633609A1 concerning methods and compositions for lyophilizing lipid nanoparticles. The patent was published on March 18, 2026, with Global Life Sciences Solutions Canada ULC listed as the applicant.

EPO Patent Publication: Anti-GDF 15 Antibody for Cancer Neoadjuvant Therapy

The European Patent Office has published patent application EP4634222A1 concerning an anti-GDF 15 antibody for the neoadjuvant therapy of cancer, filed by CatalYm GmbH. This publication details the invention and designated states for patent protection.

EPO Patent Publication EP4629997A1: ASBT Inhibitors for Renal Disease Treatment

The European Patent Office has published patent application EP4629997A1 concerning ASBT inhibitors for the treatment of renal diseases, filed by Albireo AB. The publication date is March 18, 2026.

EPO Patent Application: Antibodies Targeting Itga2 and Antibody-Drug Conjugates

The European Patent Office published patent application EP4545563A1 concerning antibodies targeting Itga2 and antibody-drug conjugates. The application lists Foreseen Technology (Beijing) Co., Ltd. and Foreseen Biotechnology (Shanghai) Co., Ltd. as applicants.

EPO Patent Bulletin: Method for Determining Anticancer Treatment Efficacy

The European Patent Office has published patent application EP4634406A1 detailing a method for determining and improving the potential efficacy of anticancer treatments. The patent application lists ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS and other research institutions as applicants.

EPO Patent Publication: Novel Human Antiviral Genes

The European Patent Office published patent application EP4630033A1 on March 18, 2026, detailing novel human antiviral genes related to prokaryotic systems. The application was filed by Institut National de la Santé et de la Recherche Médicale, Université Paris Cité, and Institut Curie.

Extracellular Matrix Compounds for Localized Therapeutic Agent Loading

The European Patent Office has published patent application EP4630443A1 concerning extracellular matrix binding compounds for localized loading of therapeutic or diagnostic agents. The application was filed by Kamino ApS and lists Andreas Lodberg, Christian Brix Folsted Andersen, and Marco Eijken as inventors.

EPO Patent: Novel Compounds as NLRP3 Inhibition Modulators

The European Patent Office has published a new patent application (EP4630417A1) for novel compounds that act as modulators of NLRP3 inhibition. The patent application was filed by F. Hoffmann-La Roche AG and lists multiple inventors.

EPO Patent EP4630402A1: Sulfonyl Derivatives as CCR6 Inhibitors

The European Patent Office has published patent application EP4630402A1 concerning sulfonyl derivatives as CCR6 inhibitors, with F. Hoffmann-La Roche AG listed as the applicant. This publication details chemical compounds and their potential therapeutic applications.

EPO Patent EP4630419A1: Novel Pyrazine-Carboxamide-Imidazopyridine Derivatives

The European Patent Office has published patent application EP4630419A1 for novel pyrazine-carboxamide-imidazopyridine derivatives, with Boehringer Ingelheim International GmbH listed as the applicant. The patent covers potential applications in treating neurological disorders and cancer.